bupranolol
Sign in to saveAlso known as BRN 2272923, SK&F 16805-A
Bupranolol is a non-selective beta blocker without intrinsic sympathomimetic activity (ISA), but with strong membrane stabilizing activity. Its potency is similar to propranolol.
Key facts
- Drug.Verifiedfields
- changed
- Drug.verifiedrevid
- 460123491
- Drug.IUPAC_name
- (RS)-1-(tert-butylamino)-3-(2-chloro-5-methylphenoxy)propan-2-ol
- Drug.image
- Bupranolol.svg
- Drug.image_class
- skin-invert-image
- Drug.routes_of_administration
- Oral, topical (eye drops)
- Drug.bioavailability
- < 10%
- Drug.protein_bound
- 76%
- Drug.metabolism
- First pass elimination > 90%
- Drug.elimination_half life
- 2-4 hours (plasma)
- Drug.excretion
- > 88% renal (as carboxybupranolol)
- Drug.CAS_number
- 14556-46-8
- Drug.ATC_prefix
- C07
- Drug.ATC_suffix
- AA19
- Drug.ChEMBL
- 305380
- Drug.StdInChI
- 1S/C14H22ClNO2/c1-10-5-6-12(15)13(7-10)18-9-11(17)8-16-14(2,3)4/h5-7,11,16-17H,8-9H2,1-4H3
- Drug.StdInChIKey
- HQIRNZOQPUAHHV-UHFFFAOYSA-N
- Drug.PubChem
- 2475
via Wikipedia infobox
Research
338 papers- Long-acting isosorbide mononitrate.Drugs · 1999
- Interactions of bupranolol with the polymorphic debrisoquine/sparteine monooxygenase (CYP2D6).European journal of clinical pharmacology · 1993
- Differences in the Antinociceptive Effects and Binding Properties of Propranolol and Bupranolol Enantiomers.The journal of pain · 2015
- Evidence that (+)-bupranolol interacts directly with myocardial beta-adrenoceptors. Control of optical purity with differential thermal analysis.Naunyn-Schmiedeberg's archives of pharmacology · 1980
- Atypical cardiostimulant beta-adrenoceptor in the rat heart: stereoselective antagonism by bupranolol but lack of effect by some bupranolol analogues.British journal of pharmacology · 2003
via PubMed
Wikidata facts
- Mass
- 271.133907
Show 3 more facts
- chemical formula
- C₁₄H₂₂ClNO₂
- World Health Organisation international non-proprietary name
- bupranolol
- canonical SMILES
- CC1=CC(=C(C=C1)Cl)OCC(CNC(C)(C)C)O
Sources (2)
via Wikidata · CC0
~1 min read
Article
5 sectionsContents
- Uses and dosage
- Pharmacology
- Adverse effects, contraindications, interactions
- References
- Further reading
Bupranolol is a non-selective beta blocker without intrinsic sympathomimetic activity (ISA), but with strong membrane stabilizing activity. Its potency is similar to propranolol.
==Uses and dosage== Like other beta blockers, oral bupranolol can be used to treat hypertension and tachycardia. The initial dose is 50 mg two times a day. It can be increased to 100 mg four times a day. Bupranolol eye drops (0.05%-0.5%) are used against glaucoma.